polivy

Generic: polatuzumab vedotin

Labeler: genentech, inc.
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name polivy
Generic Name polatuzumab vedotin
Labeler genentech, inc.
Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS
Active Ingredients

polatuzumab vedotin 140 mg/7.52mL

Manufacturer
Genentech, Inc.

Identifiers & Regulatory

Product NDC 50242-105
Product ID 50242-105_f7a11f1f-8a77-4220-9337-14c4dbc6e0dc
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761121
Listing Expiration 2026-12-31
Marketing Start 2019-06-10

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 50242105
Hyphenated Format 50242-105

Supplemental Identifiers

RxCUI
2174095 2174100 2398131 2398133
UNII
KG6VO684Z6

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name polivy (source: ndc)
Generic Name polatuzumab vedotin (source: ndc)
Application Number BLA761121 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 140 mg/7.52mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-105-01) / 20 mL in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (1)

Ingredients (1)

polatuzumab vedotin (140 mg/7.52mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "f7a11f1f-8a77-4220-9337-14c4dbc6e0dc", "openfda": {"unii": ["KG6VO684Z6"], "rxcui": ["2174095", "2174100", "2398131", "2398133"], "spl_set_id": ["20a16ab2-f338-4abb-9dcd-254bd949a2bc"], "manufacturer_name": ["Genentech, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (50242-105-01)  / 20 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "50242-105-01", "marketing_start_date": "20190610"}], "brand_name": "POLIVY", "product_id": "50242-105_f7a11f1f-8a77-4220-9337-14c4dbc6e0dc", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "product_ndc": "50242-105", "generic_name": "polatuzumab vedotin", "labeler_name": "Genentech, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "POLIVY", "active_ingredients": [{"name": "POLATUZUMAB VEDOTIN", "strength": "140 mg/7.52mL"}], "application_number": "BLA761121", "marketing_category": "BLA", "marketing_start_date": "20190610", "listing_expiration_date": "20261231"}